Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 540

1.

Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder.

McNeil BK, Sorbellini M, Grubb RL 3rd, Apolo A, Cecchi F, Athauda G, Cohen B, Giubellino A, Simpson H, Agarwal PK, Coleman J, Getzenberg RH, Netto GJ, Shih J, Linehan WM, Pinto PA, Bottaro DP.

J Transl Med. 2014 Oct 21;12(1):199. [Epub ahead of print]

PMID:
25335552
[PubMed - as supplied by publisher]
Free Article
2.

Decade in review-kidney cancer: Discoveries, therapies and opportunities.

Linehan WM, Ricketts CJ.

Nat Rev Urol. 2014 Oct 7. doi: 10.1038/nrurol.2014.262. [Epub ahead of print] No abstract available.

PMID:
25287783
[PubMed - as supplied by publisher]
3.

The somatic genomic landscape of chromophobe renal cell carcinoma.

Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M, Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK, Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA; Cancer Genome Atlas Research Network, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D, Wheeler DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJ.

Cancer Cell. 2014 Sep 8;26(3):319-30. doi: 10.1016/j.ccr.2014.07.014. Epub 2014 Aug 21.

PMID:
25155756
[PubMed - in process]
4.

Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.

Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, Srinivasan R, Linehan WM.

Nat Rev Urol. 2014 Aug;11(8):465-75. doi: 10.1038/nrurol.2014.162. Epub 2014 Jul 22.

PMID:
25048860
[PubMed - in process]
5.

Vascular Endothelial Growth Factor Receptor-Targeted Therapy in Succinate Dehydrogenase C Kidney Cancer.

Shuch B, Agochukwu N, Ricketts CJ, Vocke CD, Gautam R, Merino M, Linehan WM, Srinivasan R.

J Clin Oncol. 2014 Jul 14. pii: JCO.2013.51.0214. [Epub ahead of print] No abstract available.

PMID:
25024072
[PubMed - as supplied by publisher]
6.

Hereditary leiomyomatosis and renal cell carcinoma.

Schmidt LS, Linehan WM.

Int J Nephrol Renovasc Dis. 2014 Jun 20;7:253-60. doi: 10.2147/IJNRD.S42097. eCollection 2014. Review.

PMID:
25018647
[PubMed]
Free PMC Article
7.

Nephron-sparing surgery for multifocal and hereditary renal tumors.

Metwalli AR, Linehan WM.

Curr Opin Urol. 2014 Sep;24(5):466-73. doi: 10.1097/MOU.0000000000000094.

PMID:
25014245
[PubMed - in process]
8.

Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.

Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittomäki K, Tomlinson I, Richard S, Linehan WM.

Fam Cancer. 2014 Jul 11. [Epub ahead of print]

PMID:
25012257
[PubMed - as supplied by publisher]
9.

Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects.

Mullen AR, Hu Z, Shi X, Jiang L, Boroughs LK, Kovacs Z, Boriack R, Rakheja D, Sullivan LB, Linehan WM, Chandel NS, DeBerardinis RJ.

Cell Rep. 2014 Jun 12;7(5):1679-90. doi: 10.1016/j.celrep.2014.04.037. Epub 2014 May 22.

PMID:
24857658
[PubMed - in process]
Free Article
10.

Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK.

Goncharova EA, Goncharov DA, James ML, Atochina-Vasserman EN, Stepanova V, Hong SB, Li H, Gonzales L, Baba M, Linehan WM, Gow AJ, Margulies S, Guttentag S, Schmidt LS, Krymskaya VP.

Cell Rep. 2014 Apr 24;7(2):412-23. doi: 10.1016/j.celrep.2014.03.025. Epub 2014 Apr 13.

PMID:
24726356
[PubMed - in process]
Free PMC Article
11.

Lymphangitic retroperitoneal carcinomatosis occurring from metastatic sarcomatoid chromophobe renal cell carcinoma.

Alimchandani M, Lara K, Tsokos M, Linehan WM, Merino MJ.

Urol Case Rep. 2014 Mar 1;2(2):39-62.

PMID:
24696789
[PubMed]
12.

Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von hippel-lindau-associated pancreatic lesions.

Sadowski SM, Weisbrod AB, Ellis R, Patel D, Alimchandani M, Quezado M, Millo C, Venzon DJ, Nilubol N, Linehan WM, Kebebew E.

J Am Coll Surg. 2014 May;218(5):997-1003. doi: 10.1016/j.jamcollsurg.2014.01.004. Epub 2014 Jan 18.

PMID:
24661849
[PubMed - indexed for MEDLINE]
13.

The genetic basis of pheochromocytoma and paraganglioma: implications for management.

Shuch B, Ricketts CJ, Metwalli AR, Pacak K, Linehan WM.

Urology. 2014 Jun;83(6):1225-32. doi: 10.1016/j.urology.2014.01.007. Epub 2014 Mar 15. Review.

PMID:
24642075
[PubMed - indexed for MEDLINE]
14.

Editorial comment.

Schmidt LS, Linehan WM.

Urology. 2014 Mar;83(3):675.e5; discussion 675.e5-6. doi: 10.1016/j.urology.2013.09.070. No abstract available.

PMID:
24581541
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease.

Lonser RR, Butman JA, Huntoon K, Asthagiri AR, Wu T, Bakhtian KD, Chew EY, Zhuang Z, Linehan WM, Oldfield EH.

J Neurosurg. 2014 May;120(5):1055-62. doi: 10.3171/2014.1.JNS131431. Epub 2014 Feb 28.

PMID:
24579662
[PubMed - indexed for MEDLINE]
16.

Intratumoral heterogeneity in kidney cancer.

Ricketts CJ, Linehan WM.

Nat Genet. 2014 Mar;46(3):214-5. doi: 10.1038/ng.2904.

PMID:
24569233
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.

Prieto DA, Johann DJ Jr, Wei BR, Ye X, Chan KC, Nissley DV, Simpson RM, Citrin DE, Mackall CL, Linehan WM, Blonder J.

Biomark Med. 2014 Feb;8(2):269-86. doi: 10.2217/bmm.13.101.

PMID:
24521024
[PubMed - indexed for MEDLINE]
18.

Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.

Ricketts CJ, Hill VK, Linehan WM.

PLoS One. 2014 Jan 15;9(1):e85621. doi: 10.1371/journal.pone.0085621. eCollection 2014.

PMID:
24454902
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome.

Weisbrod AB, Kitano M, Thomas F, Williams D, Gulati N, Gesuwan K, Liu Y, Venzon D, Turkbey I, Choyke P, Yao J, Libutti SK, Nilubol N, Linehan WM, Kebebew E.

J Am Coll Surg. 2014 Feb;218(2):163-9. doi: 10.1016/j.jamcollsurg.2013.10.025. Epub 2013 Nov 12.

PMID:
24440063
[PubMed - indexed for MEDLINE]
20.

Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.

Shuch B, Vourganti S, Ricketts CJ, Middleton L, Peterson J, Merino MJ, Metwalli AR, Srinivasan R, Linehan WM.

J Clin Oncol. 2014 Feb 10;32(5):431-7. doi: 10.1200/JCO.2013.50.8192. Epub 2013 Dec 30.

PMID:
24378414
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk